NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email International students are reconsidering studying in the US due to the Trump administration’s policies, leading to a potential 30-40% drop in new enrollmentsRead More